Physician profile
Melissa H Singleton
NPI 1164597399
$482,219.14
in general payments reported to CMS, 2019-2025
10 companies · $117K in 2025
The $117K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79K · 2022: $84K · 2023: $100K · 2024: $103K · 2025: $117K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $296K · Travel and Lodging: $21K · Food and Beverage: $2,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $295,609.50 |
| Travel and Lodging | $21,492.57 |
| Food and Beverage | $2,473.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $481,437.95 | 2021-2025 | Dysport |
| Abbvie INC. | $198.59 | 2023-2025 | |
| Allergan, INC. | $187.71 | 2021-2022 | |
| Merz North America, INC. | $182.78 | 2021-2022 | |
| Janssen Biotech, INC. | $124.72 | 2021 | |
| Pfizer INC. | $30.91 | 2021-2022 | |
| Lilly USA, LLC | $18.77 | 2021 | |
| Amgen INC. | $13.05 | 2021 | |
| Dermira, INC. | $12.86 | 2021 | |
| Almirall LLC | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Singleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.